Intravenous Immunoglobulin Market, Treatment, Industry Trends, Companies, Drugs and Analysis by DelveInsight | Evolve Biologics, Biotest, Momenta Pharmaceuticals, Green Cross Pharma and Others

Intravenous Immunoglobulin Market

Intravenous immunoglobulin (also referred to as IVIG) is a product made up of antibodies that can be given intravenously. According to the American College of Rheumatology, it is prepared from a pool of immunoglobulins (antibodies) from the plasma of thousands of healthy donors.

Immunoglobulins are made by the immune system of healthy people to fight infections. While IVIG is derived from plasma (a blood product), it is so purified that the chances of contracting a blood-borne infection are extremely low.

Traditionally, IVIG has been used as replacement therapy for patients with primary or secondary immunoglobulin deficiencies.


DelveInsight’s “Intravenous Immunoglobulin Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Intravenous Immunoglobulin , historical and forecasted epidemiology as well as the Intravenous Immunoglobulin market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.


Some facts of Intravenous Immunoglobulin Market:

According to the NORD (National Organization for Rare Disorders), the incidence of ITP among adults in the United States is estimated to be around 3.3/100,000 adults/year.
As per the article by Gelfand, approximately 25–30% of IVIG used in the United States remains as replacement therapy for primary immunodeficiency disease (PID).
At present the market is currently dominated by the some of the key players, which includes Takeda (Baxter), Bio Products Laboratory, Grifols, CSL Behring, Octapharma, Kedrion Biopharma, and others.
Primary immunodeficiency diseases (PI) are a group of more than 400 rare, chronic disorders in which part of the body’s immune system is missing or functions improperly


Request for free Sample:


Scope of the Intravenous Immunoglobulin Report:

The report covers the descriptive overview of Intravenous Immunoglobulin , explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
Comprehensive insight has been provided into the Intravenous Immunoglobulin epidemiology and treatment in the 7MM
Additionally, an all-inclusive account of both the current and emerging therapies for Intravenous Immunoglobulin are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
A detailed review of Intravenous Immunoglobulin market; historical and forecasted is included in the report, covering drug outreach in the 7MM
The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Intravenous Immunoglobulin market


Request for free Sample:


Some of Intravenous Immunoglobulin Companies are:

Evolve Biologics
Momenta Pharmaceuticals
Green Cross Pharma
And Many Others


Some of Intravenous Immunoglobulin Drugs are:

PlasmaCap IG  10%
And Many Others

At present the market is currently dominated by the some of the key players, which includes Takeda (Baxter), Bio Products Laboratory, Grifols, CSL Behring, Octapharma, Kedrion Biopharma, and others.


Request for free Sample:


Table of Contents:

1. Key Insights

2. Executive Summary of Intravenous Immunoglobulin

3. Competitive Intelligence Analysis for Intravenous Immunoglobulin

4. Intravenous Immunoglobulin : Market Overview at a Glance

5. Intravenous Immunoglobulin : Disease Background and Overview

6. Patient Journey

7. Intravenous Immunoglobulin Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of Intravenous Immunoglobulin Treatment

11. Marketed Products

List to be continued in report

12. Emerging Therapies

List to be continued in report

13. Intravenous Immunoglobulin : Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Intravenous Immunoglobulin

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

Request for Deatiled TOC:


About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States